fbpx
May 13, 2020

FDA Announces Latest Step Toward Finalizing Memorandum of Understanding with States Addressing Compounded Drug Distribution, While Preserving Access

Image By: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research Compounded drugs can serve an important role for patients whose medical needs cannot be […]
May 13, 2020

Compounding Quality Center of Excellence: Virtual, Interactive Training Programs

The Compounding Quality Center of Excellence’s virtual, interactive training programs with live instruction target outsourcing facility staff and offer continuing education credits. Training will open for […]
May 13, 2020

Compounding Quality Center of Excellence: Self-Guided Online Training Courses

The Compounding Quality Center of Excellence offers free, self-guided online training courses on quality manufacturing practice requirements and compounding policies pertaining to outsourcing facilities. These courses […]
May 13, 2020

Compounding Quality Center of Excellence

FDA’s Compounding Quality Center of Excellence is focused on improving the quality of compounded drugs, primarily those made at outsourcing facilities. Compounded drugs pose unique risks […]
May 13, 2020

Fact or Fiction: What to Know About Smoking Cessation and Medications

[embedded content] Spanish Tobacco use is the leading preventable cause of death in the United States, resulting in more than 480,000 deaths annually. Almost 70 percent […]
May 12, 2020

Coronavirus (COVID-19) Update: Daily Roundup May 12, 2020

For Immediate Release: May 12, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
May 12, 2020

Is It Really ‘FDA Approved?’

Español “FDA approved!” Maybe you saw those words on a company’s website, or in a commercial promoting a new product or treatment. Some marketers may say […]
May 12, 2020

Qualified Clinical Outcome Assessments (COA)

The table below lists qualified Clinical Outcome Assessments (COA). The tables include legacy projects (those submitted prior to passage of the 21st Century Cures Act), as […]
May 12, 2020

Oncologic Drugs Advisory Committee Roster

Jaffer A. Ajani, MDExpertise: Medical OncologyTerm: 7/1/2019 – 6/30/2023Professor, Department of Gastrointestinal Medical Oncology, Division of Cancer MedicineProfessor, Department of Epidemiology, Divisionof Office of the Vice […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0